Published in J Biol Chem on April 13, 2011
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol Psychiatry (2012) 1.11
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08
Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation. Front Cell Neurosci (2011) 0.90
Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons. PLoS One (2013) 0.83
Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty. PLoS One (2013) 0.78
Early and sustained altered expression of aging-related genes in young 3xTg-AD mice. Cell Death Dis (2014) 0.78
Low dose nicotine attenuates Aβ neurotoxicity through activation early growth response gene 1 pathway. PLoS One (2015) 0.76
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease. Front Mol Neurosci (2016) 0.75
Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain. J Biol Chem (2016) 0.75
14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells. PLoS One (2016) 0.75
Cellular Prion Protein (PrP(c)) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in Health. Front Cell Neurosci (2016) 0.75
Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments. Alzheimers Dement (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 9.53
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (2007) 8.56
A decade of CDK5. Nat Rev Mol Cell Biol (2001) 5.24
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem (2004) 5.14
The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci (2001) 3.92
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med (2001) 3.84
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J (2001) 3.22
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med (2008) 3.15
Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A (2002) 3.04
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.95
Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med (2000) 2.79
Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science (1996) 2.70
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med (2009) 2.39
Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther (2006) 2.24
Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging (2001) 2.20
A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol (2004) 2.20
ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol (2001) 2.11
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem (1995) 2.09
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem (2007) 2.09
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov (2009) 2.08
Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem (2000) 2.00
Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature (1997) 1.99
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci (2009) 1.88
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther (2008) 1.86
Early growth response-1 in cardiovascular pathobiology. Circ Res (2006) 1.86
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem (1995) 1.70
Egr transcription factors in the nervous system. Neurochem Int (1997) 1.56
Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem (1993) 1.50
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol (2008) 1.47
Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene (2006) 1.45
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41
Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem (2006) 1.35
Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. J Biol Chem (1998) 1.30
Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proc Natl Acad Sci U S A (2003) 1.30
Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci (1997) 1.29
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci (2008) 1.28
Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun (1997) 1.24
Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol (2008) 1.24
Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res (1999) 1.21
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol (2007) 1.21
Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol (1999) 1.19
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci (2008) 1.18
EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells. Oncogene (2009) 1.17
Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol Ther (2008) 1.17
Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport (1993) 1.16
Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci U S A (1996) 1.16
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett (2007) 1.08
Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J Biol Chem (2002) 1.03
Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol (1997) 1.03
Physical interaction between p53 and primary response gene Egr-1. Int J Oncol (2001) 1.02
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry (2006) 1.02
Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem (2004) 1.02
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol (2005) 1.01
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol (2009) 1.00
Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry (2006) 0.99
Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol (1998) 0.99
Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro. J Biol Chem (2009) 0.96
Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation. J Biol Chem (1995) 0.95
Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition. J Biol Chem (1999) 0.94
Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J Biol Chem (2007) 0.94
The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase. J Biol Chem (1997) 0.93
Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2. Int J Cancer (1998) 0.92
Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J Biol Chem (2000) 0.91
Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro. J Biol Chem (1997) 0.89
Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther (2005) 0.89
Suppression of transcription factor Egr-1 by curcumin. Thromb Res (2000) 0.87
Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol (1997) 0.86
Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging (2000) 0.85
Does lithium therapy protect against the onset of dementia? Alzheimer Dis Assoc Disord (2005) 0.84
Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1. Am J Physiol Cell Physiol (2005) 0.81
The topography and subcellular distribution of mitogen-activated protein kinase kinase1 (MEK1) in adult rat brain and differentiating PC12 cells. Neuroscience (1999) 0.77
Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell (2008) 3.11
Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem (2004) 2.85
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation (2002) 2.84
Hydrogen production from formic acid decomposition at room temperature using a Ag-Pd core-shell nanocatalyst. Nat Nanotechnol (2011) 2.21
Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol (2006) 2.17
The veA gene activates sexual development in Aspergillus nidulans. Fungal Genet Biol (2002) 1.92
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther (2004) 1.79
Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity. J Biol Chem (2008) 1.65
Long-distance intercellular connectivity between cardiomyocytes and cardiofibroblasts mediated by membrane nanotubes. Cardiovasc Res (2011) 1.64
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211. J Infect Dis (2009) 1.61
Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci (2009) 1.54
A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer (2002) 1.38
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Am J Pathol (2006) 1.33
Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. PLoS One (2012) 1.32
C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc Natl Acad Sci U S A (2011) 1.31
Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol (2011) 1.30
Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci (2007) 1.29
APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development. J Neurosci (2005) 1.26
AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol (2012) 1.24
Role of electronic excitation in the amorphization of Ge-Sb-Te alloys. Phys Rev Lett (2011) 1.22
Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine (2010) 1.19
Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett (2007) 1.18
Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling. J Biol Chem (2008) 1.16
Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One (2010) 1.14
14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem (2003) 1.13
Papillomavirus infection requires gamma secretase. J Virol (2010) 1.12
Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. Cancer Epidemiol Biomarkers Prev (2004) 1.12
Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects. J Clin Pharmacol (2009) 1.11
Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury. J Neurochem (2006) 1.11
S-palmitoylation of gamma-secretase subunits nicastrin and APH-1. J Biol Chem (2008) 1.09
A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat Cell Biol (2013) 1.08
Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res (2005) 1.07
Aptamer-mediated efficient capture and release of T lymphocytes on nanostructured surfaces. Adv Mater (2011) 1.07
Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer. Mol Cell Biol (2002) 1.05
Establishment of totipotency does not depend on Oct4A. Nat Cell Biol (2013) 1.05
A method for patterning multiple types of cells by using electrochemical desorption of self-assembled monolayers within microfluidic channels. Angew Chem Int Ed Engl (2007) 1.05
Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. Antiviral Res (2009) 1.04
The CUBLAS and CULA based GPU acceleration of adaptive finite element framework for bioluminescence tomography. Opt Express (2010) 1.04
miR-20a promotes prostate cancer invasion and migration through targeting ABL2. J Cell Biochem (2014) 1.04
Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J Biol Chem (2002) 1.03
No platelet can adhere--largely improved blood compatibility on nanostructured superhydrophobic surfaces. Small (2005) 1.02
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry (2006) 1.02
Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology (2011) 1.02
Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro. J Virol (2002) 1.01
Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev (2007) 0.99
The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis. Nanotechnology (2008) 0.99
Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry (2006) 0.99
Bio-inspired hierarchical macromolecule-nanoclay hydrogels for robust underwater superoleophobicity. Adv Mater (2010) 0.99
Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo. Int Immunopharmacol (2007) 0.98
Tension pneumopericardium leads to cardiac tamponade during hand-assisted ventilation in patients with uremia. J Thorac Cardiovasc Surg (2008) 0.98
[Impact of intensive insulin therapy on surgical critically ill patients]. Zhonghua Wai Ke Za Zhi (2007) 0.98
Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol (2006) 0.97
Regulation of RAGE for attenuating progression of diabetic vascular complications. Exp Diabetes Res (2011) 0.97
Role of Rac1 GTPase in JNK signaling and delayed neuronal cell death following global cerebral ischemia. Brain Res (2009) 0.96
Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma. J Med Virol (2012) 0.96
Targeted ablation of the chromogranin a (Chga) gene: normal neuroendocrine dense-core secretory granules and increased expression of other granins. Mol Endocrinol (2006) 0.96
Flight performance of the orange wheat blossom midge (Diptera: Cecidomyiidae). J Econ Entomol (2013) 0.96
Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci (2010) 0.96
MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis. J Genet Genomics (2011) 0.96
Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro. J Biol Chem (2009) 0.96
Hydrophobic interaction-mediated capture and release of cancer cells on thermoresponsive nanostructured surfaces. Adv Mater (2012) 0.95
Correlation between the phenotypes and genotypes of X-linked hypohidrotic ectodermal dysplasia and non-syndromic hypodontia caused by ectodysplasin-A mutations. Eur J Med Genet (2011) 0.95
Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels. Eur J Pharmacol (2014) 0.95
Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem (2010) 0.95
Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol (2007) 0.94
APH1 polar transmembrane residues regulate the assembly and activity of presenilin complexes. J Biol Chem (2009) 0.94
Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J Biol Chem (2007) 0.94
Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster. Gene (2006) 0.93
Selection of oocytes for in vitro maturation by brilliant cresyl blue staining: a study using the mouse model. Cell Res (2007) 0.93
14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem (2004) 0.93
Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. ACS Nano (2009) 0.93
Peroxisome proliferator-activated receptor γ coactivator1- gene α transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle. J Physiol (2012) 0.92
Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model. Appl Microbiol Biotechnol (2012) 0.92
Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients. Antivir Ther (2010) 0.92
An adaptive regularization parameter choice strategy for multispectral bioluminescence tomography. Med Phys (2011) 0.92
Clinical features of the retinopathy, globe enlarged (rge) chick phenotype. Vision Res (2003) 0.92
Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects. J Clin Pharmacol (2010) 0.92
Enemy or partner: relationship between intronic micrornas and their host genes. IUBMB Life (2012) 0.92
Non-syngas direct steam reforming of methanol to hydrogen and carbon dioxide at low temperature. Nat Commun (2012) 0.92
[Status of perfluorochemicals in adult serum and umbilical blood in Shenyang]. Wei Sheng Yan Jiu (2004) 0.91
Stereospecific interaction between immune cells and chiral surfaces. J Am Chem Soc (2007) 0.91
Total variation regularization for bioluminescence tomography with the split Bregman method. Appl Opt (2012) 0.91
Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the RhoA/ROCK pathway. J Orthop Res (2010) 0.91
Biomechanopharmacology: a new borderline discipline. Trends Pharmacol Sci (2006) 0.90
The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J Neurochem (2009) 0.90
[A comparison of bispectral index and sedation agitation scale in guiding sedation therapy: a randomized controlled study in patients undergoing short term mechanical ventilation]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2011) 0.90
Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom (2009) 0.89
Molecular cloning and characterization of four heat shock protein genes from Macrocentrus cingulum (Hymenoptera: Braconidae). Mol Biol Rep (2009) 0.89
Two novel heterozygous mutations of EVC2 cause a mild phenotype of Ellis-van Creveld syndrome in a Chinese family. Am J Med Genet A (2011) 0.89
Robust anatomical landmark detection for MR brain image registration. Med Image Comput Comput Assist Interv (2014) 0.88
Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int (2007) 0.88
The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis. J Cancer Res Ther (2014) 0.88